TrialDrug and alcohol dependence2014

Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.

Paolo Mannelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.